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Abstract 
Introduction: Smart glasses can be adapted to display radiographic images to allow 
clinician’s gaze not to be directionally fixed or predetermined by computer monitor 
location. This study presents an analysis of eye lens dose during interventional 
fluoroscopy guided procedures, comparing fixed monitor positions against the use of 
smart glasses. 
Methods: Using a head phantom (simulating the clinician), thermoluminescent 
dosimeters and lead shielded glasses, the dose to the eye was measured for 
different head ‘rotations and tilts’ for: gaze directed towards the main scattering 
source (patient / primary beam) to represent potential gaze direction if smart glasses 
are used; gaze directed to a range of potential computer monitor positions. An 
anthropomorphic pelvis phantom was utilised to simulate the patient. Accumulated 
dose rates (µGy.sˉ¹) from five 10-second exposures at 75 kV 25.2 mAs were 
recorded.  
Results: An average DAP reading of 758.84 cGy.cm2 was measured during each 
10 second exposure. Whilst wearing lead shielded glasses a 6.10 – fold reduction in 
dose rate to the lens is possible (p<0.05). Influence of the direction of gaze by the 
clinician demonstrated a wide range of dose rate reduction from 3.13% (p=0.16) to 
143.69% (p<0.05) when the clinician’s gaze was towards the main scattering source.  
Increased dose rate to the clinician’s eyes was received despite wearing lead 
shielded glasses, as the angle of gaze moved 45º and 90º from 0º. 
Conclusion: If the clinician’s gaze is directed towards the main scattering source a 
potential exists for reducing eye lens dose compared with fixed location computer 
monitors. Introduction of lead lined smart glasses into interventional radiology may 
lead to improvements in patient care, reducing the need for the clinician to look away 
from the patient to observe a radiographic image. 
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Introduction 
The introduction of smart glasses, such as Google Glass,1 has enabled real time 
communication via the internet to facilitate information exchange through integrated 
display screens, high definition camera, microphone; wireless connectivity allows the 
wearer to be independent of physical internet connections. This technology has the 
potential to be used by medical and surgical practitioners in both practise2, 3 and 
education.4 
The potential for smart glasses in interventional radiology has previously been 
considered,5-7 concluding that they can offer improvements in patient safety, operator 
comfort and procedure efficiency. During these procedures the clinician may be 
looking at their hands, equipment or a real time image on a computer monitor 
produced either by a Computer Tomography (CT) scanner, fluoroscopy or an 
ultrasound machine.7 The location of these monitors however may not be 
convenient, requiring the clinician to look away from their hands and patient. It may 
also be required to move the monitors during procedures when manipulating the C 
arm into cranial and caudal angles. Furthermore, the monitors may be partially 
obscured by other equipment. The use of smart glasses may offer a solution to these 
problems, enabling the clinician to direct their gaze wherever they like as the images 
would appear within the smart glasses rather than on computer monitors located 
somewhere in the clinical room.8 In turn this may result in procedures being 
completed faster and safer as the clinician would be able to observe the live 
radiographic image without looking away from the patient. Additionally, clinicians are 
able to record the procedure for future teaching purposes.7 
Aside from improving safety and efficiency, smart glasses have potential radiation 
protection benefits to clinicians. Damage to biological tissue by ionising radiation is 
dependant partly on the amount of radiation received9 and its use in medicine is 
continuously increasing.10 Fluoroscopy is often the imaging technique of choice for 
interventional radiology procedures, but it is associated with a higher radiation 
dose,11, 12 especially in relation to the clinician’s eye lens. The lens of the clinician’s 
eye is one of the most radiosensitive structures in the human body and is located 
within a high intensity region for fluoroscopy radiation dose.13, 14 The potential of 
radiation to cause lens opacities or cataracts is deterministic and has been 
highlighted in the 2011 International Commission on Radiological Protection (ICRP) 
publication 118. This makes it essential for eye lens protection to be worn by 
clinicians during fluoroscopy guided procedures, especially for any clinician who has 
to stand close to the patient and the x-ray source.15-17 Dose limits set by the ICRP for 
the eye lens are 20 mSv per year over 5 years for the lens, with a maximum of 50 
mSv per year.18  
Previous work has focussed either on the reduction of eye dose whilst wearing lead 
shielded glasses17 or how smart glasses (not lead lined) may influence the clinician’s 
practise during interventional fluoroscopy procedures.8 To the authors’ knowledge no 
research has been conducted on what the dose implications would be to the 
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clinician’s eyes if wearing lead lined augmented reality smart glasses. Using 
phantoms, this study’s purpose was to analyse radiation dose to a simulated 
clinician’s eyes during interventional fluoroscopy-guided procedures comparing fixed 
monitor positions against the use of smart glasses.   
Methods 
A quality controlled Ultimax-i Toshiba Fluoroscopy (Canon Medical Systems, 
Japan) machine was used; the recommended standards for routine performance test 
results complied with IPEM report No 9119 and the machine was in routine clinical 
use. An adult lower sectional torso RSD anthropomorphic pelvis phantom RS-113T 
(Universal Medical, USA) was utilised to simulate an average male patient, 
representing comparable absorption and scattering characteristics of human tissue. 
The phantom was positioned supine on the imaging table and centred at the midline 
of the couch, simulating an actual clinical setting. The table was raised to a height of 
1 meter from the floor and the fluoroscopy flat panel detector was 32 cm above the 
table top. This set up was based on a similar phantom experiment measuring 
clinician eye doses in interventional fluoroscopy procedures.17 The centring point 
used during the examination was in the midline between the anterior superior iliac 
spine and superior border of the pubic symphysis, which is a typical centring point for 
an anteroposterior (AP) pelvis. Collimation was kept at maximum throughout the 
experiment at 43 × 43 cm to allow sufficient scatter for the collection of reliable data 
for this study. There was no angulation of the C arm to maintain experimental set-up.  
A Rando anthropomorphic head phantom SK150 (The Phantom Laboratory, USA) 
simulating the clinician was positioned to the right of the patient representing a 
clinical environment, at a distance of 60 cm perpendicular from the nearest edge of 
the flat panel detector. It is known that at this position the clinician will be exposed to 
the least amount of radiation, due to a shielding effect caused by the flat panel 
detector.20 The height of the head phantom was 168.5 cm, determined by the mean 
average height of both a male and female British person.21 
Accumulated dose rates to the clinician’s eye lenses from five 10-second 
exposures at 75 kV 25.2 mAs with a focal spot size of 1 mm and a tantalum filter 
were recorded for different angles of gaze to decrease random error, therefore 
promoting higher levels of accuracy. The acquisition parameters were consistent 
with those used in a clinical fluoroscopy guided percutaneous procedure for the 
pelvis.22 Flat panel detector exposures were made with the phantom head, with no 
cranial or caudal angulation, at 0°, 45°, and 90° horizontal gazes to represent 
clinician gaze towards fixed location computer monitors. Each direction of gaze has 
been labelled A – E as shown in Figure 1 for reference. Directions B – D were 
repeated with the phantom head tilted at a caudal angle of 15° to represent potential 
gaze of the clinician if smart glasses are worn (towards the main scattering source / 
patient). Rothband Sportswrap lead shielded glasses with 0.75 mm Pb lens and 0.50 
mm Pb side shields (Rothband, England, UK)23 were used to cover the eyes of the 
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phantom. The experiment was conducted for each angle of gaze both with and 
without the head phantom wearing the lead shielded glasses. Figure 2 shows the 
setup of the experiment. 
 Nine calibrated high sensitivity LiF:Mg, Cu thermoluminescent dosimeters (TLDs) 
type P-100H (Thermo Scientific, USA) were used to measure the cumulated 
radiation dose on both the left and right eye of the phantom, arranged as shown in 
Figure 3. Their tissue equivalency (Zeff TLD = 8.04 compared to Zeff tissue = 7.42) has a 
similar response to radiation as human tissue.24 The dose rate (µGy.s-1) for each eye 
was calculated from the accumulated dose of all 9 TLDs by determining their mean 
value. The mean value was then divided by 5 to give the mean value of the five 10-
second exposures. The mean value was then further divided by 10 to give the dose 
rate in seconds. The TLDs used on the day of the experiment were from 3 different 
batches and were calibrated separately per batch as described by Tootell, 
Szczepura, and Hogg (2013).25 An uncertainty of less than 10% total in dosimetric 
results by TLDs has to be achieved in accordance with the European Commission.26 
Sensitivity difference of each batch was determined to be less than 3%. Calculated 
consistency was 99% and total uncertainty was 4%. To remove any residual charge 
the TLDs were annealed at 240°C for 10 minutes in a rapid cooling oven (TLD/3, 
Carbolite, England, UK) equipped with a Eurotherm 3508 temperature 
programmable controller. The TLDs were read in a Harshaw 3500 TLD (Thermo 
Scientific, USA), with associated software (WinREMS) on a personal computer.24 
The experiment was conducted in a single time slot over one day. 
Bar charts were produced to compare dose rates at different directions of gaze 
both with and without lead shielded glasses. A percentage difference comparison 
between dose rate received at fixed monitor positions against the clinician’s gaze 
directed towards the main scattering source (representing the use of smart glasses) 
for each eye was calculated from 
|𝑉1 − 𝑉2|
(𝑉1 + 𝑉2)
2
× 100 
Where V1 and V2 are value 1 and value 2 of dose rate, respectively. A Shapiro – Wilk 
(SW) test was applied to assess the normality of the data to select a suitable 
statistical test for data analysing.  A paired t-test (for parametric data) was utilised to 
compare the dose rate measured by the 9 TLDs with and without wearing lead 
shielded glasses across different angles of gaze at a horizontal angle and at a 15° 
caudal angle for both the left and right eye. 
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Figure 1. Diagram representing clinician’s angle of gaze (A - E used for reference). 
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Figure 2. Experimental set up. 
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Figure 3. TLD arrangement on simulated clinician’s eyes. 
 
 
8 
 
Results 
A comparison between the dose rate received from the simulated clinician’s eyes 
for the varying head positions A – E with no 15° caudal angle (as represented in 
Figure 1) with and without wearing lead shielded glasses is presented in Figure 4. 
The SW test showed a normal distribution for all the data, hence error bars were 
calculated by standard deviation from the dose rate of the 9 TLDs on each eye. A 
reduction in dose rate for both eyes was greatest when the simulated clinician’s gaze 
was in position C, looking directly at the main scattering source whilst wearing lead 
shielded glasses. This is also seen when the experiment was repeated with the 
simulated clinician’s head at a 15° caudal angle looking directly at the phantom 
pelvis (Figure 5.). The dose rate with the simulated clinician’s head at a 15° caudal 
angle is also smaller when compared with no head tilt. When the simulated 
clinician’s gaze was at positions A and E with no 15° caudal angle, the smallest 
reduction in dose rate was measured when the simulated clinician wore lead 
shielded glasses.  
Tables 1 and 2 presents the scatter dose values for 10 second exposure (µGy), 
dose rates values (µGy.sˉ1), and the differences in dose rate values as percentages 
for the varying simulated computer monitor positions versus the lowest dose rate 
measurement. The lowest dose rate measurement was identified as the simulated 
clinician’s gaze at position C with a 15° caudal head tilt whilst wearing lead shielded 
glasses. The percentage difference was calculated to show what reduction in dose 
rate can be achieved if the clinician opted to use lead lined augmented reality smart 
glasses. Tables 3 and 4 show the p values for the SW test and the p values of the 
paired t-test of the 9 TLDs on each eye for the different angles of gaze. A paired t-
test calculation demonstrates that there is a statistically significant difference 
(p<0.05) in dose rates with and without wearing lead shielded glasses for most 
angles.    
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Figure 4. Comparison between the dose rate received to the simulated clinician’s 
eyes at a horizontal angle for the varying head positions A – E, where (R) and (L) 
represent the right and left eye respectively and error bars represent standard 
deviation of the dose rate measured from 9 TLDs. 
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Figure 5. Comparison between the dose rate received to the simulated clinician’s 
eyes at a 15° caudal angle for the varying head positions B – D, where (R) and (L) 
represent the right and left eye respectively and error bars represent standard 
deviation of the dose rate measured from 9 TLDs. 
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Table 1. Dose rates and the percentage dose rate difference in comparison to the 
lowest dose rate measured at the right eye (0.58 µGy.s-1) and the left eye (0.63 
µGy.s-1) for the different angles of gaze at a horizontal angle. 
Angle of Gaze  
Eye 
Right (R) / 
Left (L) 
Lead 
Shielded 
Glasses 
(Y/N) 
Scatter Dose 
for 10 
second 
exposure 
(µGy) 
Dose Rate 
(µGy.s-1) 
Percentage 
difference of 
dose rate 
A R Y 20.31 2.03 111.11 
A R N 25.28 2.53 125.40 
A L Y 8.19 0.82 26.21 
A L N 5.56 0.56 11.76 
B R Y 6.32 0.63 8.26 
B R N 31.76 3.18 138.30 
B L Y 9.67 0.97 42.50 
B L N 16.19 1.62 88.00 
C R Y 6.39 0.64 9.84 
C R N 30.44 3.04 135.92 
C L Y 6.86 0.69 9.09 
C L N 31.05 3.11 132.62 
D R Y 7.33 0.73 22.90 
D R N 20.02 2.00 110.08 
D L Y 7.45 0.75 17.39 
D L N 29.78 2.98 130.19 
E R Y 8.22 0.82 34.29 
E R N 8.22 0.82 34.29 
E L Y 31.53 3.15 133.33 
E L N 35.31 3.53 139.42 
 
  
12 
 
Table 2. Dose rates and the percentage dose rate difference in comparison to the 
lowest dose rate measured at the right eye (0.58 µGy.s-1) and the left eye (0.63 
µGy.s-1) for the different angles of gaze at a 15° caudal angle. 
Angle of Gaze 
Eye 
Right (R) / 
Left (L) 
Lead 
Shielded 
Glasses 
(Y/N) 
Scatter Dose 
for 10 
second 
exposure 
(µGy) 
Dose Rate 
(µGy.s-1) 
Percentage 
difference of 
dose rate  
B R Y 6.43 0.64 9.84 
B R N 33.86 3.39 141.56 
B L Y 6.46 0.65 3.13 
B L N 24.35 2.44 117.92 
C R Y 5.75 0.58 N/A 
C R N 35.37 3.54 143.69 
C L Y 6.35 0.63 N/A 
C L N 34.75 3.47 138.54 
D R Y 6.01 0.60 3.39 
D R N 3.27 3.27 139.74 
D L Y 6.46 0.65 3.13 
D L N 32.50 3.25 135.05 
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Table 3. Shapiro – Wilk (SW) test p values and p values of the paired t-test for the 
different angles of gaze at a horizontal angle. 
Angle of Gaze 
Eye 
Right (R) / 
Left (L) 
Lead Shielded 
Glasses (Y/N) SW p- value 
Paired t-test 
p-value 
A R Y 0.420 <0.05 
A R N 0.647 <0.05 
A L Y 0.234 <0.05 
A L N 0.261 <0.05 
B R Y 0.293 <0.05 
B R N 0.764 <0.05 
B L Y 0.570 <0.05 
B L N 0.764 <0.05 
C R Y 0.125 <0.05 
C R N 0.445 <0.05 
C L Y 0.668 0.19 
C L N 0.568 <0.05 
D R Y 0.279 0.11 
D R N 0.295 <0.05 
D L Y 0.778 <0.05 
D L N 0.293 <0.05 
E R Y 0.607 <0.05 
E R N 0.527 <0.05 
E L Y 0.697 < 0.05 
E L N 0.282 < 0.05 
Table 4. Shapiro – Wilk (SW) test p values and p values of the paired t-test for the 
different angles of gaze at a 15° caudal angle 
Angle of Gaze 
Eye 
Right (R) / 
Left (L) 
Lead Shielded 
Glasses (Y/N) SW p- value 
Paired t-test 
p-value 
B R Y 0.504 <0.05 
B R N 0.945 <0.05 
B L Y 0.751 0.16 
B L N 0.590 <0.05 
C R Y 0.646 N/A 
C R N 0.102 <0.05 
C L Y 0.709 N/A 
C L N 0.675 <0.05 
D R Y 0.318 0.43 
D R N 0.754 <0.05 
D L Y 0.918 0.74 
D L N 0.408 <0.05 
 
14 
 
Discussion 
This phantom – based study has shown the potential of wearing lead impregnated 
augmented reality smart glasses for reducing the amount of radiation received to the 
interventional clinician’s eye lens. It has demonstrated that the clinician receives a 
higher rate of radiation dose during an exposure if looking away from the pelvis 
phantom and looking towards potential locations of monitors. As shown in tables 1 - 
4 a percentage difference of dose rate can be attained from a range of 3.13% to 
143.69%. A paired t-test established that for most angles of gaze a statistical 
significant difference (p<0.05) was observed. A few exceptions were determined 
where there is no statistically significant difference (p>0.05) at angles B – D when 
the clinician was wearing lead shielded glasses, where the dose measured was very 
similar with position C at a 15° caudal angle. In realistic conditions the clinician will 
always turn towards the monitor when an exposure takes place.20 The lowest dose 
rate recorded was when the angle of gaze was directly looking at the pelvis 
phantom. This is where, during an exposure, the clinician’s direction of gaze could 
be if wearing smart glasses.  
Our results also show that whilst wearing lead shielded glasses a 6.10 – fold 
reduction in dose rate to the lens is possible (p<0.05), which is in agreement with 
previous studies.14, 27 An important observation is the increased dose rate the 
clinician’s eyes receive despite wearing lead shielded glasses, as the angle of gaze 
moves to 45º and 90º from 0º with no caudal head tilt. This was also seen in a 
previous study by Ekpo et al14 who hypothesised that as the angle of gaze moves 
away from the scattering source, backscatter radiation from the glasses to the lens is 
received to the clinician. In contrast, a decrease in dose rate was measured for the 
same movement when the phantom clinician did not wear lead shielded glasses for 
the furthermost eye from the scattering source. As both eyes were measured in this 
study, it was confirmed that the eye closest to the scattering source would receive a 
higher dose rate of radiation in comparison to the eye furthest away from the 
scattering source, both with and without the presence of lead shielded glasses whilst 
the phantom clinician was at positions A and E. This trend however was not as 
prominent at positions B and D, with dose rate measured to be similar at both eyes. 
We propose with the use of lead lined smart glasses during interventional 
procedures, there would be a reduction in the amount of time the clinician would 
need to look away from the patient. Significantly reducing dose rate received to the 
lens helping to keep the dose below the threshold for cataracts.  
Limitations of this work may include the uncertainties from errors in the TLD 
readings28 the sensitivity of the TLDs used in this study were 0.028. The 
experimental room did not fully account for a true interventional radiology 
environment, as the use of phantoms were employed for this study. Collimation was 
kept fully open throughout the experiment, which does not truly represent actual 
clinical practice. The simulated clinician did not change location during this study 
which should be addressed in future research. The clinician would be required to 
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change their position throughout the procedure which is known to have an impact on 
eye dose.20, 29 The distance between the clinician and scattering source has 
remained fixed in this study, however it is likely to change within a real clinical 
environment. It has been shown previously when there is a decrease in proximity 
from the patient there is a reduction in dose received to the eye lens.30 Although all 
effort was taken to ensure a 15° caudal angle was achieved, this may not have been 
perfectly attained for each angle of gaze. The measured scatter cannot be solely 
attributed to the scattering source (pelvis phantom) as the tube location was not 
shielded i.e. no leaded table skirt31. It is recommended that for future work greater 
ecological validity be assured with the use of a leaded skirt to remove this limitation. 
Also, as a head phantom was used to replicate the clinician, further shielding from a 
lead gown and thyroid shield was not possible, which would absorb scattered 
radiation32. No measures were taken to account for multiple scatter events from 
within the head phantom. Throughout the experiment the C arm remained static, for 
the purposes of this pilot study experiment (potential dose protection from the use of 
lead lined smart glasses) there was no need to move the C arm to different angles. It 
is noted however that moving the C arm would have an impact on the results.17, 33 
This study supports further research for glasses use and testing within the clinical 
setting. Further research is recommended into how changing the C arm angle affects 
dose rate to the clinician’s eye lenses. Additionally, the distance between the patient 
table and operators eyes20, 33, the size of the irradiated volume34 along with the 
exposure parameters34, 35 can affect the dose to the operator and these have 
remained constant in this study. Future work could also include the testing of lead 
line smart glasses within an actual interventional procedure, to establish the impact 
of clinician’s gaze. This would also determine whether wearing smart glasses 
resulted in increased observation of the patient by the clinician. TLDs are highly 
sensitive for measuring low level scatter radiation,36 a strength of this work. The 
experiment was conducted on the same day to increase the accuracy of this work, 
ensuring the same experimental set up was achieved, a further strength of this work.  
Conclusion 
A significant reduction in dose rate to the phantom’s eye was received when 
looking directly at the scattering source whilst wearing lead shielded glasses. This 
experimental study has shown evidence of the potential for dose reduction to the 
clinician’s eye lens. Preliminary experimental findings indicate a new standard of 
practise may therefore be introduced whilst wearing lead lined augmented reality 
smart glasses eliminating the need for the clinician to look at fixed position computer 
monitors during exposures. By introducing lead lined smart glasses into 
interventional radiology, potential improvements in patient care can be made as the 
clinician will not always need to look away from the patient to observe a radiographic 
image. Observation of the patient is particularly important as interventional 
procedures become more complicated and longer in duration. Smart glasses have 
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the potential to make improvements to patient management as they allow the 
clinician to monitor the patient more dynamically. Further research is needed to 
assess the efficacy of using smart glasses in interventional procedures, to include 
clinician acceptability of the technology. 
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